# Oxytocin Add on Study for Stable Schizophrenic Patients

> **NCT00506909** · NA · TERMINATED · sponsor: **David Feifel** · enrollment: 21 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00506909
- **Lead sponsor:** David Feifel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Break in funding
- **Last updated:** 2019-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00506909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00506909, "Oxytocin Add on Study for Stable Schizophrenic Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00506909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*